AI Verdict
NUTX has stronger fundamentals based on our AI analysis.
NUVI vs NUTX Fundamental Comparison
| Metric | NUVI | NUTX |
|---|---|---|
| Revenue | N/A | $875.3M |
| Net Income | $-8,869.0 | $70.8M |
| Net Margin | N/A | 8.1% |
| ROE | N/A | 21.5% |
| ROA | N/A | 7.7% |
| Current Ratio | 0.00x | 3.41x |
| Debt/Equity | N/A | 0.09x |
| EPS | N/A | $10.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NUVI vs NUTX: Frequently Asked Questions
Is NUVI or NUTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NUTX has stronger fundamentals. NUVI is rated STRONG SELL (95% confidence) while NUTX is rated STRONG BUY (85% confidence). This is not investment advice.
How does NUVI compare to NUTX fundamentally?
Emo Capital Corp. has ROE of N/A vs Nutex Health Inc.'s 21.5%. Net margins are N/A vs 8.1% respectively.
Which stock pays higher dividends, NUVI or NUTX?
NUVI has a dividend yield of N/A or no dividend while NUTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NUVI or NUTX for long term?
For long-term investing, consider that NUVI has STRONG SELL rating with 95% confidence, while NUTX has STRONG BUY rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NUVI vs NUTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NUVI vs NUTX, the AI consensus favors NUTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.